Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by PADMANEE SHARMA and HAVEN REBECCA GARBER.
PADMANEE SHARMA
Connection Strength
0.275
HAVEN REBECCA GARBER
  1. Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer. Oncotarget. 2024 Mar 19; 15:238-247.
    View in: PubMed
    Score: 0.238
  2. Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma. NPJ Genom Med. 2017; 2.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.